Oura Ring Gen 4 sensor data, not clinical measurementsN=1 case study, not validated for clinical decisionsHEV diagnosed Mar 18; Day 205 post-ruxolitinibMore
Consumer wearable data can support exploratory review only. The HEV diagnosis, temporally confounded with treatment start, remains a material confounder.

Weekly Tracker

2026-10-01 to 2026-10-07
GREEN
On Track
10
Metrics in normal range
AMBER
Watch
0
Borderline or declining
RED
Alert
2
Needs attention
IMPROVING
In range
7
Week-over-week
DECLINING
Info
2
Week-over-week

Doctor Summary - Week of 2026-10-01 to 2026-10-07

  • ATTENTION: Steps is declining at 4420 steps (-14.9% week-over-week)
  • ATTENTION: Temp Deviation is declining at 0.24 °C (+16.7% week-over-week)
  • HRV (RMSSD) improved +42.7% to 24.7 ms
  • Recovery Index improved +30.4% to 84 pts
  • Day 205 on ruxolitinib (started 2026-03-16)
METRICS

Metric Details

HRV (RMSSD)
24.7ms
↑ +42.7%Last week: 17.3 ms
Lowest HR
56.3bpm
↓ -7.9%Last week: 61.1 bpm
Average HR
63.5bpm
↓ -8.1%Last week: 69.1 bpm
Sleep Duration
6.2h
↔ +1.4%Last week: 6.1 h
Deep Sleep
1.5h
↑ +16.8%Last week: 1.3 h
REM Sleep
1.4h
↑ +13.4%Last week: 1.2 h
Sleep Efficiency
86%
↔ +2.7%Last week: 84 %
Readiness Score
73pts
↑ +14.8%Last week: 63 pts
Recovery Index
84pts
↑ +30.4%Last week: 64 pts
Steps
4420steps
↓ -14.9%Last week: 5197 steps
Temp Deviation
0.24°C
↓ +16.7%Last week: 0.21 °C
Breath Rate
14.9brpm
↔ +1.6%Last week: 14.6 brpm
RUXOLITINIB

Ruxolitinib Progress

Day 205 on ruxolitinib (started 2026-03-16)

MetricPre-Rux BaselineThis WeekChange
HRV (RMSSD)11.7 ms24.7 ms↑ +110.6%
Lowest HR73.0 bpm56.3 bpm↓ -22.8%
Average HR80.5 bpm63.5 bpm↓ -21.1%
Sleep Duration6.0 h6.2 h↑ +2.9%
Deep Sleep1.0 h1.5 h↑ +45.9%
REM Sleep0.8 h1.4 h↑ +64.5%
Sleep Efficiency79 %86 %↑ +8.9%
Readiness Score69 pts73 pts↑ +5.1%
Recovery Index63 pts84 pts↑ +33.2%
Steps2540 steps4420 steps↑ +74.0%
Temp Deviation0.21 °C0.24 °C↑ +16.7%
Breath Rate14.0 brpm14.9 brpm↑ +6.5%